Literature DB >> 11914272

Rescue of neural tube defects in Pax-3-deficient embryos by p53 loss of function: implications for Pax-3- dependent development and tumorigenesis.

Lydie Pani1, Melissa Horal, Mary R Loeken.   

Abstract

Pax-3 is a transcription factor that is expressed in the neural tube, neural crest, and dermomyotome. We previously showed that apoptosis is associated with neural tube defects (NTDs) in Pax-3-deficient Splotch (Sp/Sp) embryos. Here we show that p53 deficiency, caused by germ-line mutation or by pifithrin-alpha, an inhibitor of p53-dependent apoptosis, rescues not only apoptosis, but also NTDs, in Sp/Sp embryos. Pax-3 deficiency had no effect on p53 mRNA, but increased p53 protein levels. These results suggest that Pax-3 regulates neural tube closure by inhibiting p53-dependent apoptosis, rather than by inducing neural tube-specific gene expression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11914272      PMCID: PMC155364          DOI: 10.1101/gad.969302

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  36 in total

1.  PAX3 is expressed in human melanomas and contributes to tumor cell survival.

Authors:  F A Scholl; J Kamarashev; O V Murmann; R Geertsen; R Dummer; B W Schäfer
Journal:  Cancer Res       Date:  2001-02-01       Impact factor: 12.701

2.  Predominant expression of alternative PAX3 and PAX7 forms in myogenic and neural tumor cell lines.

Authors:  F G Barr; J C Fitzgerald; J P Ginsberg; M L Vanella; R J Davis; J L Bennicelli
Journal:  Cancer Res       Date:  1999-11-01       Impact factor: 12.701

3.  Dual inactivation of RB and p53 pathways in RAS-induced melanomas.

Authors:  N Bardeesy; B C Bastian; A Hezel; D Pinkel; R A DePinho; L Chin
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

4.  Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development.

Authors:  Y Gao; D O Ferguson; W Xie; J P Manis; J Sekiguchi; K M Frank; J Chaudhuri; J Horner; R A DePinho; F W Alt
Journal:  Nature       Date:  2000-04-20       Impact factor: 49.962

5.  DNA ligase IV deficiency in mice leads to defective neurogenesis and embryonic lethality via the p53 pathway.

Authors:  K M Frank; N E Sharpless; Y Gao; J M Sekiguchi; D O Ferguson; C Zhu; J P Manis; J Horner; R A DePinho; F W Alt
Journal:  Mol Cell       Date:  2000-06       Impact factor: 17.970

6.  A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy.

Authors:  P G Komarov; E A Komarova; R V Kondratov; K Christov-Tselkov; J S Coon; M V Chernov; A V Gudkov
Journal:  Science       Date:  1999-09-10       Impact factor: 47.728

7.  Diabetic embryopathy in C57BL/6J mice. Altered fetal sex ratio and impact of the splotch allele.

Authors:  A F Machado; E F Zimmerman; D N Hovland; R Weiss; M D Collins
Journal:  Diabetes       Date:  2001-05       Impact factor: 9.461

8.  An engineered PAX3-KRAB transcriptional repressor inhibits the malignant phenotype of alveolar rhabdomyosarcoma cells harboring the endogenous PAX3-FKHR oncogene.

Authors:  W J Fredericks; K Ayyanathan; M Herlyn; J R Friedman; F J Rauscher
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

9.  Expression of Pax-8, p53 and bcl-2 in human benign and malignant thyroid diseases.

Authors:  F Puglisi; D Cesselli; G Damante; L Pellizzari; C A Beltrami; C Di Loreto
Journal:  Anticancer Res       Date:  2000 Jan-Feb       Impact factor: 2.480

10.  Migration of cardiac neural crest cells in Splotch embryos.

Authors:  J A Epstein; J Li; D Lang; F Chen; C B Brown; F Jin; M M Lu; M Thomas; E Liu; A Wessels; C W Lo
Journal:  Development       Date:  2000-05       Impact factor: 6.868

View more
  86 in total

1.  The closely related transcription factors Sox4 and Sox11 function as survival factors during spinal cord development.

Authors:  Daniela C Thein; Johannes M Thalhammer; Anna C Hartwig; E Bryan Crenshaw; Veronique Lefebvre; Michael Wegner; Elisabeth Sock
Journal:  J Neurochem       Date:  2010-08-03       Impact factor: 5.372

2.  FOXD3 is a mutant B-RAF-regulated inhibitor of G(1)-S progression in melanoma cells.

Authors:  Ethan V Abel; Andrew E Aplin
Journal:  Cancer Res       Date:  2010-03-23       Impact factor: 12.701

3.  Activation of p38 MAP kinase by DNA double-strand breaks in V(D)J recombination induces a G2/M cell cycle checkpoint.

Authors:  Gustavo Pedraza-Alva; Miroslav Koulnis; Colette Charland; Tina Thornton; James L Clements; Mark S Schlissel; Mercedes Rincón
Journal:  EMBO J       Date:  2006-02-02       Impact factor: 11.598

4.  Pax3 mRNA is decreased in the hearts of rats with experimental diaphragmatic hernia.

Authors:  S Gonzalez-Reyes; V Fernandez-Dumont; W Martinez-Calonge; L Martinez; F Hernandez; Ja Tovar
Journal:  Pediatr Surg Int       Date:  2004-12-23       Impact factor: 1.827

5.  Regulation of Schwann cell differentiation and proliferation by the Pax-3 transcription factor.

Authors:  Robin D S Doddrell; Xin-Peng Dun; Roy M Moate; Kristjan R Jessen; Rhona Mirsky; David B Parkinson
Journal:  Glia       Date:  2012-04-24       Impact factor: 7.452

6.  Lineage-specific responses to reduced embryonic Pax3 expression levels.

Authors:  Hong-Ming Zhou; Jian Wang; Rhonda Rogers; Simon J Conway
Journal:  Dev Biol       Date:  2007-12-27       Impact factor: 3.582

7.  Cardiac outflow tract septation failure in Pax3-deficient embryos is due to p53-dependent regulation of migrating cardiac neural crest.

Authors:  Sarah C Morgan; Hyung-Yul Lee; Frédéric Relaix; Lisa L Sandell; John M Levorse; Mary R Loeken
Journal:  Mech Dev       Date:  2008-07-13       Impact factor: 1.882

8.  Guilty as CHARGED: p53's expanding role in disease.

Authors:  Jeanine L Van Nostrand; Laura D Attardi
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

9.  Oxidant regulation of gene expression and neural tube development: Insights gained from diabetic pregnancy on molecular causes of neural tube defects.

Authors:  T I Chang; M Horal; S K Jain; F Wang; R Patel; M R Loeken
Journal:  Diabetologia       Date:  2003-03-26       Impact factor: 10.122

10.  Necdin enhances myoblasts survival by facilitating the degradation of the mediator of apoptosis CCAR1/CARP1.

Authors:  Stephanie François; Cristina D'Orlando; Tiziana Fatone; Thierry Touvier; Patrizia Pessina; Raffaella Meneveri; Silvia Brunelli
Journal:  PLoS One       Date:  2012-08-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.